Aug 13, 2020
Armata Pharmaceuticals Announces Second Quarter 2020 Results and Provides General Corporate Update
Jun 17, 2020
Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections
Jun 16, 2020
Plasma Air Ionization Proven to Reduce Coronavirus Surrogate MS2 Bacteriophage by 99% in Independent Spanish Testing
May 14, 2020
Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update
Apr 27, 2020
Phagelux AgriHealth Announces Multiple Agricultural Commercial Collaborations
Apr 27, 2020
Novaerus Defend 1050 Proven to Reduce Coronavirus Surrogate by 99.99%
Mar 30, 2020
Armata Pharmaceuticals Announces Closing of Second Tranche of $25 Million Securities Purchase Agreement with Innoviva, Inc.
Jan 08, 2020
Adaptive Phage Therapeutics Awarded Initial Contract with Department of Defense
Jan 08, 2020
Locus Biosciences initiates world's first controlled clinical trial for a CRISPR enhanced bacteriophage therapy
Dec 04, 2019
Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill 'Superbugs' as Part of Bear's Den Innovation Program
Nov 13, 2019
J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease
Nov 12, 2019
Armata Pharmaceuticals Announces Third Quarter Results and Provides Corporate and Clinical Update
Oct 31, 2019
Armata Pharmaceuticals Issues Letter to Shareholders
Oct 21, 2019
Armata Pharmaceuticals Announces Receipt of $1.3 million R&D Tax Incentive
Oct 15, 2019
Global Phage Therapy Market Report 2019 with Focus on the United States
Sep 30, 2019
BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria
Sep 19, 2019
Armata Pharmaceuticals to Participate in the Ladenburg Thalmann 2019 Healthcare Conference
Sep 12, 2019
Armata Pharmaceuticals Announces Development of New Synthetic Phage Candidate Targeting Pseudomonas aeruginosa
Aug 27, 2019
BiomX Announces In-house Phage Manufacturing Facility
Aug 01, 2019
Armata Pharmaceuticals to Provide Corporate Update at the 39th Annual Canaccord Genuity Growth Conference